ANTILEISHMANIAL ACTIVITY OF SELECTED FDA-APPROVED DRUGS IN A MURINE CUTANEOUS LEISHMANIASIS MODEL

被引：0
|
作者：
Saunders, David [1 ]
Li, Qiqui [2 ]
Carlson, Misty [2 ]
Xie, Lisa [2 ]
Zheng, Qiang [2 ]
Zhang, Jing [2 ]
Mendez, Juan [2 ]
Tally, John [2 ]
Jiang, Suping [2 ]
Weina, Peter [2 ]
Magill, Alan [2 ]
Grogl, Max [2 ]
机构：
[1] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand
[2] Walter Reed Army Inst Res, Silver Spring, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2009年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
750
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [41] Repackaging FDA-approved drugs for degenerative diseases: promises and challenges
    Cummings, Jeffrey L.
    Zhong, Kate
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (02) : 161 - 165
  • [42] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [43] Illegitimate companies threaten patients' receipt of FDA-approved drugs
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (19) : 1646 - 1647
  • [44] Mechanisms of action for FDA-approved drugs targeting breast cancer
    Dhilna, Francis
    Binitha, R. N.
    Riswina, Nissar
    Divya, Sebatain
    Rima, Joseph
    Janish, P. A.
    Subin, Balachandran
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2025, 38 (01):
  • [45] Identification of FDA-approved drugs that induce heart regeneration in mammals
    Ahmed, Mahmoud Salama
    Nguyen, Ngoc Uyen Nhi
    Nakada, Yuji
    Hsu, Ching-Cheng
    Farag, Ayman
    Lam, Nicholas T.
    Wang, Ping
    Thet, Suwannee
    Menendez-Montes, Ivan
    Elhelaly, Waleed M.
    Lou, Xi
    Secco, Ilaria
    Tomczyk, Mateusz
    Zentilin, Lorena
    Pei, Jimin
    Cui, Miao
    Dos Santos, Matthieu
    Liu, Xiaoye
    Liu, Yan
    Zaha, David
    Walcott, Gregory
    Tomchick, Diana R.
    Xing, Chao
    Zhang, Cheng Cheng
    Grishin, Nick V.
    Giacca, Mauro
    Zhang, Jianyi
    Sadek, Hesham A.
    NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (3): : 372 - 388
  • [46] Scientists Repurposing FDA-Approved Drugs to Fight against Viruses
    YAN Fusheng
    Bulletin of the Chinese Academy of Sciences, 2019, 33 (03) : 187 - 188
  • [47] Genetic support for FDA-approved drugs over the past decade
    Polina V. Rusina
    Maria J. Falaguera
    Juan Maria R. Romero
    Ellen M. McDonagh
    Ian Dunham
    David Ochoa
    Nature Reviews Drug Discovery, 2023, 22 : 864 - 864
  • [48] An analysis of FDA-approved drugs for infectious disease: antibacterial agents
    Kinch, Michael S.
    Patridge, Eric
    Plummer, Mark
    Hoyer, Denton
    DRUG DISCOVERY TODAY, 2014, 19 (09) : 1283 - 1287
  • [49] An analysis of original research contributions toward FDA-approved drugs
    Patridge, Eric V.
    Gareiss, Peter C.
    Kinch, Michael S.
    Hoyer, Denton W.
    DRUG DISCOVERY TODAY, 2015, 20 (10) : 1182 - 1187
  • [50] In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability
    Staud, Roland
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (10) : JC118 - JC118
12345